Buccal
Fat
Removal

Learning objective

Given a consultation transcript and mixed-quality images, produce a baseline note that quotes the patient's own cheek-contour goal, separates observations from hypotheses, rates image comparability, and names at least two unanswered questions.

In this lesson

• Translate an aesthetic label into the person's goal: Ask which cheek region, view, expression, and everyday situation matters to the patient, and what they would want to preserve. “Slimmer face” may mean a cheek hollow, a jaw border, a change after weight fluctuation, or a wish to resemble an edited image. Record the patient's own words before the clinician proposes an anatomical target. Explore whether the request is voluntary and whether external pressure or a time-limited social trend is shaping it; do not diagnose a psychological condition from one conversation. ASPS candidates; GMC cosmetic communication.
• Record a usable clinical baseline: Keep reported concern, relevant history, weight trend, prior facial procedures, and clinician-observed cheek and lower-face features in separate fields. Describe bilateral observations and known asymmetry without converting normal difference into pathology. Ask about facial symptoms and prior treatment that may affect evaluation. An in-person, appropriately qualified assessment is needed to interpret tissue contribution and health context; a selfie is not an anatomical diagnosis. ASPS consultation.
• Rate visual evidence rather than merely collecting it: A frontal image with neutral expression and a consistent profile may support later comparison, but angle, lens, lighting, expression, makeup, and recent weight changes can alter apparent cheek fullness. Mark each supplied photograph as comparable, limited, or unsuitable and explain why. Do not infer buccal-fat size, a precise future contour, or a treatment target from filters or shadowing. Clinical images used in teaching require separate permission and secure handling under applicable rules. ASPS consultation; GMC visual-recording principles.
• Close with an assessment question, not a booking decision: Summarize what is known, what the patient wants, and why the current record cannot yet attribute the concern to buccal fat. Ask what examination, stable-weight history, standardized view, or colleague's opinion would change the assessment. Record a feature the patient does not want altered and an acceptable “no procedure” outcome. A reviewable baseline prevents later outcome discussions from drifting to a new ideal that the patient never requested. ASPS consultation; GMC decision principles.

Learning objective

Build a cheek-volume contribution map for a fictional patient, classifying each candidate contributor as observed, plausible, contradicted, or unresolved and naming the assessment needed to resolve uncertainty.

In this lesson

• Define the target of the question: Buccal fat removal is intended to reduce fullness in the cheek-hollow region, not to directly change cheekbone projection, bite, skin quality, or submental contour. The buccal pad varies between people and sides, so bilateral facial symmetry cannot be assumed from one view. Describe this broad anatomy at a conceptual level; do not teach a surgical route or resection target. ASPS overview.
• Compare plausible contributors without false certainty: Surface fat, skin and soft-tissue quality, cheekbone projection, masseter prominence, jaw contour, posture, and recent weight change may affect perceived lower-face shape. Some are outside the scope of buccal-fat reduction and may warrant another service's assessment. The exercise is a differential of appearance, not a diagnosis or a claim that any one alternative reliably reproduces a cheek hollow. A photograph can locate the patient's concern but cannot establish which tissue produces it. ASPS consultation; ASPS overview.
• Understand nearby structures as safety context: A cadaveric study found variable relationships between the buccal fat pad, facial-nerve branches, and parotid duct. That variability supports respect for nerve and salivary-duct injury in counseling and qualified supervision. The study's anatomical configurations are not observed injury events in living patients and must not be taught as a clinical complication rate or a navigation map. Hwang et al. 2005; ASPS safety.
• Make the attribution test explicit: For each proposed contributor, record the patient's report, the observed finding, evidence against it, and missing examination or history. Ask whether removing cheek-hollow volume would plausibly address the person's stated concern and what valued fullness might be lost. If the answer is uncertain, defer a procedure choice and arrange assessment or referral within the clinician's competence. A correct attribution map can conclude that no intervention is currently justified. ASPS consultation; GMC cosmetic communication.

Learning objective

For three fictional candidacy scenarios, record individualized factors supporting assessment, reasons to defer, and missing information without applying a universal age, body-mass, or cheek-width cutoff.

In this lesson

• Use candidacy guidance as a conversation framework: ASPS describes good general health, stable weight, realistic expectations, nonsmoking, and an internally motivated concern as candidate considerations. These are prompts for a qualified assessment, not a checklist that automatically approves surgery. Record comorbidities, medication and prior-procedure history as questions for the treating clinician; do not suggest changes to medication or a preoperative protocol in course work. ASPS candidates; ASPS consultation.
• Treat changing weight as an uncertainty, not a numerical rule: A recent, ongoing, or planned weight change can alter broader facial appearance and compromise a baseline comparison. Ask about the trend and the patient's priorities; consider deferral while the context is clarified. A cross-sectional MRI study found associations between age, body-mass index, and deep facial-fat volumes in its sample, but cannot predict within-person future volume or produce a candidate cutoff. Do not state that the buccal pad follows a fixed weight or aging trajectory. Fernandez et al. MRI study; ASPS candidates.
• Discuss conservation in a thin or narrow face: ASPS warns that removing buccal fat from a thin, narrow face may lead to a gaunt appearance with age. Explain this as a material possibility, especially when the patient values current cheek softness or is already concerned about hollowing. No published photograph or simple demographic characteristic can determine their eventual appearance. If the anticipated tradeoff conflicts with the person's goal, a decision to decline or defer can be clinically defensible. ASPS overview; 2026 outcomes review.
• Keep vulnerability and function in scope: Ask whether expectations are stable, voluntary, and realistically linked to a cheek-hollow change. A request driven by pressure or persistent distress warrants sensitive exploration and, where appropriate, a qualified colleague's assessment rather than a remote psychological label. Clinical symptoms or an issue outside the clinician's expertise change the pathway to assessment or referral. Document the reason for pause and what information would permit a fresh discussion; deferral is an active decision, not abandonment. GMC cosmetic communication.

Learning objective

Produce a four-path option comparison for a fictional cheek-contour request that includes no procedure, deferral, appropriate referral, and a qualified procedure discussion, with target, uncertainty, and patient-valued tradeoffs for each.

In this lesson

• Offer no procedure as a genuine option: The patient may decide that preserving fullness and avoiding surgical harm matters more than a more hollow cheek. Record that decision positively and identify whether the person wants a future review or no further contact. Avoid framing refusal as failure or using a time-limited sales prompt. A clinician who concludes that the intervention is unlikely to achieve the person's goal should explain this and not provide it merely because the patient requests it. GMC cosmetic communication.
• Use deferral to resolve a specific uncertainty: If weight is changing, images are unreliable, expectations are unsettled, or a clinical concern has not been assessed, write exactly what is missing and who will review it. Deferral has a clear trigger for reconsideration, not an invented universal waiting interval. The patient remains free to decline even after further information is available. ASPS candidates; GMC decision principles.
• Compare targets without implying equivalence: A cheek-hollow reduction, a change to cheekbone or midface projection, and a submental or jaw-border intervention address different anatomy and may have different risk profiles. If the patient's concern lies outside the buccal region, refer to a qualified clinician for that question; do not promise that another intervention will reproduce a desired filter or treat alternatives as interchangeable. The course discusses option families, not procedure specifications or a combined operative plan. ASPS overview; ASPS consultation.
• Build a balanced options record: For each path, document the patient-owned benefit sought, likely anatomical target, material harms or burden, what evidence cannot resolve, and the next decision-maker. Include how a second opinion may help when target attribution or trust is unclear. Avoid a false ranking of options based on noncomparative case series or before-and-after photographs. The result is a shared decision aid that makes non-intervention visible and preserves the patient's right to change their mind. GMC cosmetic communication; 2021 systematic review.

Learning objective

Given an ASPS risk list, one cadaveric report, and two systematic-review abstracts, produce a plain-English evidence note that names at least five material harms, distinguishes study populations and denominators, and states what cannot be predicted for an individual.

In this lesson

• Explain material harms in the patient's terms: ASPS lists asymmetry, bleeding, infection, sensory change, persistent pain, prolonged swelling, poor healing, salivary-duct injury, facial-nerve injury with possible weakness, little visible change, and revision as possible risks; anesthesia and general surgical harms also belong in a qualified discussion. Ask which outcomes the patient most fears and what loss of cheek softness would mean to them. The list is neither exhaustive nor a rate table. The treating specialist should address patient-specific medical and procedural risk in the actual consent discussion. ASPS safety; GMC cosmetic communication.
• Do not convert cadaver anatomy into injury incidence: Hwang and colleagues described anatomical relationships in 19 fixed cadaver hemifaces; five had a particular facial-nerve branch configuration. The authors speculated about an injury “chance,” but no living patient was treated and no clinical nerve injury was counted. State the valid inference—relationships vary and nearby structures matter—while refusing the invalid inference that five of nineteen patients are injured. Do not use the paper as a dissection or operative-location guide. Hwang et al. 2005.
• Compare outcome studies by their definitions: A 2025 review reports postoperative events in 81 of 308 patients and high heterogeneity; its event set includes common, sometimes transient swelling, mouth-opening limitation, and pain. A 2026 review reports 39 complications among 921 procedures included in its complication analysis and acknowledges low-level studies and short follow-up. Those are not matched cohorts, units, or event definitions. They cannot be subtracted, averaged, or presented as an individual's probability, nor can low observed counts prove that serious harm is impossible. Albuquerque et al. 2025; Shapiro et al. 2026.
• Keep benefits and long-term uncertainty in one record: Published reports can show cheek-volume reduction and favorable short-term satisfaction in selected groups, but weak designs, incomplete patient-reported measures, and limited follow-up leave later hollowing and aging effects uncertain. A 2021 review found only four eligible studies and little long-term evidence. Explain that “not established” is not the same as “will never happen” or “inevitable.” Record the patient's desired benefit and unacceptable tradeoff alongside the unresolved evidence question. Traboulsi-Garet et al. 2021; Shapiro et al. 2026; ASPS overview.

Learning objective

Write a fictional, reviewable proceed/defer/refer decision record that contains the patient's own goal, options, material risks, evidence uncertainty, opportunity for reflection, remaining questions, and follow-up responsibility.

In this lesson

• Test whether the proposed outcome matches the patient: Revisit the exact cheek region and desired degree of change, the baseline uncertainty, and what the patient wants preserved. The clinician should explain when reduction appears unlikely to meet the goal or provide overall benefit, including when the main complaint is elsewhere or valued fullness may be lost. An informed request is not itself an indication. If the clinician believes the intervention would not benefit the patient, the GMC standard calls for explaining and not providing it. The local legal and professional framework governs actual practice. GMC cosmetic communication; ASPS consultation.
• Make alternatives, harms, and uncertainty understandable: Include no procedure, deferral, relevant referral, and any qualified procedure discussion. Explain the material risks that matter to this patient, including asymmetry, nerve or duct injury, poor healing, minimal change, and later hollowing concerns. Say which expected benefit is plausible and which appearance or timeline cannot be guaranteed. Offer enough detail for a voluntary decision without reading the patient a statistical estimate that does not fit them. Invite questions, use accessible language, and document what the patient understood and still wants to know. ASPS safety; GMC decision principles.
• Protect the choice from pressure: Explore whether family, trends, deadlines, financial offers, or a social image are driving the request and whether the patient needs additional support to participate. Provide time for reflection proportionate to the decision and make clear that the person can change their mind. Explain clinical charges and potential follow-up or revision costs transparently in actual practice; the course's $19/$29 educational prices are unrelated to clinical fees. Do not equate a signed form with an adequate conversation. GMC cosmetic communication; GMC decision principles.
• Document a conditional decision and ownership: A “proceed” record is only a reasoned specialist recommendation subject to the actual treating team's full assessment and valid consent, not an instruction to book from a course exercise. “Defer” names the unresolved issue and trigger for revisit; “refer” identifies the qualified recipient and who confirms the handoff. Record the patient's own words, information shared, alternatives considered, clinical rationale, agreed action, and any dissent or unanswered question. Do not let a form or another team member silently assume responsibility. GMC recording decisions; GMC cosmetic communication.

Learning objective

Given a fictional discharge record, produce a patient-facing follow-up handoff that identifies the responsible team, individualized instruction owner, planned review, uncertainty about early contour, and a reachable route for new concerns.

In this lesson

• Make the recovery conversation usable: The treating team should translate its individual plan into language the patient can repeat: who is responsible, which instructions apply, what questions remain, and how to ask for clarification. Audit a handoff for missing contact details and unexplained terms instead of designing a generic regimen. ASPS describes site care, concerns to watch, and follow-up as subjects for individualized instructions; the patient should receive a plan from the actual treating clinician. Communication support may be needed for language, hearing, literacy, or accessibility. ASPS recovery; GMC cosmetic communication.
• Name routine and out-of-hours ownership: Assign an accountable treating clinician or suitably qualified team member for planned review, plus a route to qualified help outside usual hours. If care transfers, the handover should identify who receives messages, who acts, and who updates the patient. Written information should be adequate for another professional to continue care, subject to consent and confidentiality rules. A future appointment is insufficient if the patient cannot reach the team or an unresolved message has no owner. The GMC continuity rules are UK-specific and must be reconciled with local requirements. GMC cosmetic communication.
• Explain appearance uncertainty without dismissing symptoms: Swelling can obscure early contour, but that does not mean every new symptom is “normal” or that final appearance can be judged on a fixed date. Photographs taken with different angles, lighting, expressions, or weight context can mislead. Invite the patient to report a worrying change even if swelling was previously discussed. Document the question and response, and route a possible clinical problem for qualified assessment rather than cosmetic reassurance. ASPS notes that results vary and cannot be guaranteed. ASPS results; ASPS safety.
• Close the communication loop: Confirm that the patient knows the next review, the regular and after-hours contact routes, and what to do if a response does not arrive. Record who provided the written information, whether it was received, and who will follow up an unresolved question. A teach-back prompt can expose a confusing explanation but does not substitute for clinical examination. Keep administrative appointment tracking separate from symptom escalation; each requires a named owner and a fallback if contact fails. GMC cosmetic communication; ASPS recovery.

Learning objective

Given a postoperative message describing new symptoms, route it to qualified assessment or a local emergency pathway as appropriate, document uncertainty, and complete a referral handoff with a confirmed recipient and owner.

In this lesson

• Record symptoms before appearance interpretation: Start with the person's description, onset and change, relevant history, and ability to reach care; do not diagnose from a portal message or photograph. New facial weakness, concerning pain, bleeding, discharge, or unusual swelling may relate to material harms discussed before consent and need qualified assessment. An uneven image cannot establish whether the cause is swelling, injury, preexisting asymmetry, or something else. Preserve the patient's words and mark missing facts when passing the concern to a clinician. ASPS safety.
• Match escalation to the concern and local pathway: A designated suitably qualified clinician determines urgency under the organization's protocol. Severe systemic or cardiopulmonary symptoms require the local emergency system, not a routine cosmetic queue. Do not invent a threshold that declares a symptom safe, ask the patient to self-diagnose, or offer treatment instructions from an educational case. The ASPS risk list prompts assessment of concerning changes; it is not proof of a particular diagnosis. ASPS safety; ASPS results.
• Complete a closed-loop handoff: A referral is not complete when a message is merely sent. Identify the receiving clinician or service, why assessment is sought, relevant treatment and symptom history, how a response will be obtained, and who confirms that the patient was actually seen. Record acceptance, failed contact, and the fallback required by local policy. Tell the patient where to go and how the original team remains involved. The GMC supports qualified contacts and continuity information; actual pathways depend on jurisdiction and service. GMC cosmetic communication.
• Audit the event without retroactive reassurance: Record when a concern arrived, who reviewed it, what uncertainty remained, what was communicated, and whether the handoff closed. A later favorable photograph cannot erase an earlier unreviewed symptom. If a safety event is identified, the treating service should follow its disclosure and quality-review requirements. The fictional exercise audits whether the process worked; it does not infer a diagnosis or complication frequency from one event. GMC safety and quality; GMC cosmetic communication.

Learning objective

Compare a fictional later contour concern with the patient's original goal and baseline, distinguish plausible contributors and evidence gaps, and write a neutral assessment or referral plan without assuming revision is indicated.

In this lesson

• Return to the patient-owned goal: Begin with what the person originally sought and what they now experience, including satisfaction, distress, physical symptoms, and the location of perceived hollowing. Ask whether the present goal differs from the first one. Compare current examination and patient report with the documented baseline and earlier counseling. A new priority matters, but it does not prove that the initial treatment caused every later facial change. Real-world photographs used for care and education have different consent and confidentiality requirements. ASPS consultation; GMC recording decisions.
• Keep competing explanations visible: Weight change, ordinary facial change, other procedures, asymmetry, lighting, expression, and weak baseline images can all affect a later comparison. ASPS cautions about a gaunt appearance after volume reduction in a thin or narrow face, but that is not proof of a uniform aging effect or the sole cause in one patient. A qualified clinician should examine the person where clinical judgment is needed. Label direct observation, patient report, and causal hypothesis separately; compare photographs only when conditions make them reasonably comparable. ASPS overview; Fernandez et al. MRI study.
• Audit outcomes within the evidence limits: The 2026 systematic review reports generally favorable observations in included studies but says long-term effects are poorly assessed; the 2021 review similarly found weak long-term evidence. Do not translate a pooled event proportion or one report of gaunt appearance into a personal forecast. Record the patient's experience and unwanted effects alongside clinician observations. A measured or photographed difference may support a descriptive comparison but cannot replace the person's own goal or establish lifetime durability. Shapiro et al. 2026; Traboulsi-Garet et al. 2021; ASPS results.
• Treat revision as a new decision: A dissatisfied patient deserves renewed assessment, an explanation of uncertainty, and room for no further intervention, observation, or an appropriately qualified second opinion. Do not promise that restoration or revision can recreate the former face, and do not teach a corrective technique in this course. If any new procedure is considered, reassess current health, goal, alternatives, material risks, and consent; original consent does not authorize it. Document the agreed next step and who communicates the outcome. GMC cosmetic communication; ASPS results.